Author:
Symons Rebecca,Daly Daniel,Gandy Robert,Goldstein David,Aghmesheh Morteza
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference100 articles.
1. • Aparicio T, Pachev A, Laurent-Puig P, Svrcek M. Epidemiology, risk factors and diagnosis of small bowel adenocarcinoma. Cancers. 2022;14(9):2268. This reference is of importance as it is the most recent extensive overview of this disease including epidemiology, risk factors and management.
2. Surveillance, Epidemiology, and End Results (SEER). Cancer of the small intestine – cancer stat facts. 2022; Available from: https://seer.cancer.gov/statfacts/html/smint.html. Accessed 22 Jul 2022.
3. ••Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JV, Boye K. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(1):20–33. This reference is of major importance as it is the most up-to-date guidelines for the management of gastrointestinal stromal tumours.
4. Khosla D, Dey T, Madan R, Gupta R, Goyal S, Kumar N, Kapoor R. Small bowel adenocarcinoma: an overview. World J Gastrointest Oncol. 2022;14(2):413.
5. Yu J, Refsum E, Perrin V, Helsingen LM, Wieszczy P, Løberg M, et al.. Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel. Ann Oncol. 2022.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献